000			03858nam a22003735i 4500
001			82051
003			ES-MaUEC
005			20230207040353.0
007			cr nn 008mamaa
008			150204s2015 xxu| s |||| 0|eng d
020			_a9781493920358
024	7		_a10.1007/978-1-4939-2035-8 _2doi
050		4	_aRC280.B8 _b2015 EB
245	1	0	_aDuctal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer _cedited by Lisa A. Newman, Jessica M. Bensenhaver.
260			_aNew York _bSpringer _c2015
300			_a1 recurso en línea (XIII, 168 páginas) _b35 ilustraciones, 32 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aEpidemiology of Ductal Carcinoma In Situ -- Role of Screening Mammography in Early Detection/Outcome from Breast Cancer -- Imaging DCIS: Digital/Film Screening Mammography, Tomosynthesis, MRI, Ultrasonography -- Pathology of Ductal Carcinoma In Situ: Features and Diagnostic Challenges -- Molecular Markers in DCIS -- History of Ductal Carcinoma In Situ Management Based Upon Data from Prospective, Randomized Clinical Trials -- Extent and Role of Margin Control for DCIS Managed by Breast-Conserving Surgery -- Ductal Carcinoma In Situ Treated With Breast Conserving Surgery Alone -- DCIS Managed with BCS: Whole-Breast XRT vs. Partial Breast XRT -- Anti-HER2/neu Therapy in DCIS -- Role of Genetic Profiling and Recurrence Scores in Treatment Planning for DCIS -- DCIS and Sentinel Lymph Node Biopsy -- Role of Postmastectomy Radiation for DCIS -- Monitoring and Surveillance Following DCIS Treatment -- DCIS and Hereditary Susceptibility for Breast Cancer -- Introduction, Evolution and Application of the Van Nuys Prognostic Index in DCIS -- Disparities in DCIS Detection and Outcomes Related to Race/Ethnicity.
520	3		_aThis volume reviews the Â{u5DAF}lution of information regarding the epidemiology of DCIS and its modes of detection, as wellÂ{u0873} treatment options as a function of both clinical trial data and ongoing investigational therapeutic prospects. Several of the challenging and clinically-relevant scenarios of DCIS that appear in daily practice is discussed, including the difficulties of distinguishing “trueâ€ăIS from borderline patterns of other breast diseases and the therapeutic implications of differentiating these various diagnoses. Particular attention is paid to pathologic evaluation of DCIS, including histologic patterns and the importance of margin evaluation/margin control. The text also explores the data regarding DCIS in medical research in hereditary susceptibility for breast cancer and race/ethnicity-associated disparities in breast cancer. Written by experts in the field, Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer is a comprehensive, state-of-the art review of the field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in breast cancer.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aCáncer _xCirugía _2embne _9175031
650	2	7	_aCáncer _xCirugía _2embne _9175031
650		7	_aGinecología _2embne _9138562
700	1		_aNewman, Lisa A _eeditor literario _991606 _0Local
700	1		_aBensenhaver, Jessica M. _eeditor literario _0Local _994704
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-2035-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12906906 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gxxu _h0
945			_aRC280.B8 D838 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11574598 _z06-04-17
999			_c82051 _d82051 _x1